P
Patient Square Capital
Acquirer counsel
Kirkland & Ellis
Maggie D. Flores, P.C.Partner
Zach MillerPartner
13 lawyers involved
Rainmaker
Loading page...
Kirkland & Ellis advises Patient Square Capital on $2.6 billion acquisition from Premier, Inc.
Deal Overview
- Value
- $2.6bn
- Deal type
- M&A
- Structure
- Data in progress
- Status
- Data in progress
Advisors
ACQUIRER
Kirkland & Ellis Overview
- Patient Square Capital is a healthcare-focused investment firm with more than US$14 billion in assets under management, investing in growth-oriented companies whose products and technologies improve health.
- An affiliate of Patient Square agreed to acquire Premier in a take-private transaction for US$28.25 per share in cash, valuing Premier at US$2.6 billion and representing a premium of nearly 24% to Premier's 60-day volume-weighted average share price as of Sept. 5.
- The transaction was announced on September 22, 2025 and is expected to close in the first quarter of calendar 2026, subject to Premier stockholder approval, regulatory approvals and other customary conditions; after closing, Premier will delist from Nasdaq.
P
Premier, Inc.
Seller counsel
Cravath, Swaine & Moore LLP
Richard HallPartner
Daniel J. CerqueiraPartner
G · E · Z
George E. ZobitzPartner
1 lawyer involved
Cravath, Swaine & Moore LLP Overview
- Premier is a technology-driven health care improvement company. The announcement describes it as a leading player in that segment.
- Patient Square agreed to acquire Premier in a transaction valued at USD 2.6 billion, with Premier stockholders to receive USD 28.25 in cash per share.
- The deal was announced on September 22, 2025 and is being executed under a definitive agreement that Premier's board unanimously approved.